drugset / Trial / NCT01407835

Biological Standardization of Dactylis Glomerata Allergen Extract

NCT01407835

Phase 2 Completed 31 enrolled Laboratorios Leti, S.L.
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The objective of this study is to determine the biologic activity of a Dactylis glomerata allergen extract in histamine equivalent prick (HEP) units, in order to be used as in-house reference preparation (IHRP).

Timeline

Start
2011-10
Primary completion
2012-03
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dactylis glomerata allergen extract Unknown
Background Histamine Small molecule 10 mg/ml

Indications